BIANCO, ROBERTO

BIANCO, ROBERTO  

DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 156 (tempo di esecuzione: 0.021 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model. 1.1 Articolo in rivista 2004 Raben, D; Bianco, C; Damiano, Vincenzo; Bianco, Roberto; Melisi, Davide; Mignogna, C; D'Armiento, FRANCESCO PAOLO; Cionini, L; Bianco, Ar; Tortora, Giampaolo; Ciardiello, F; Bunn, P.
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy. 1.1 Articolo in rivista 2007 Morgillo, F; Bareschino, Ma; Bianco, Roberto; Tortora, Giampaolo; Ciardiello, F.
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. 1.1 Articolo in rivista 2006 Morelli, Mp; Cascone, T; Troiani, T; Tuccillo, C; Bianco, Roberto; Normanno, N; Romano, M; Veneziani, BIANCA MARIA; Fontanini, G; Eckhardt, Sg; DE PLACIDO, Sabino; Tortora, Giampaolo; Ciardiello, F.
Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies. 1.1 Articolo in rivista 2007 Tortora, Giampaolo; Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Mccubrey, Ja; Ricciardi, Mr; Ciuffreda, L; Cognetti, F; Tafuri, A; Milella, M.
Key cancer cell signal transduction pathways as therapeutic targets. 1.1 Articolo in rivista 2006 Bianco, Roberto; Melisi, Davide; Ciardiello, F; Tortora, Giampaolo
CHEMOSENSITIZATION BY ANTISENSE OLIGONUCLEOTIDES TARGETING MDM2. 1.1 Articolo in rivista 2005 Bianco, Roberto; Ciardiello, F; Tortora, Giampaolo
The rationale for the combination of selective EGFR inhibitors with cytotoxic drugs and radiotherapy. 1.1 Articolo in rivista 2007 Tortora, Giampaolo; Gelardi, T; Ciardiello, F; Bianco, Roberto
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. 1.1 Articolo in rivista 2007 Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo
ANTITUMOR ACTIVITY OF ZD6474, A VEGFR-2 AND EGFR SMALL MOLECULE TYROSINE KINASE INHIBITOR, IN COMBINATION WITH SC-236, A CYCLOOXYGENASE-2 INHIBITOR. 1.1 Articolo in rivista 2005 Tuccillo, C; Romano, M; Troiani, T; Martinelli, E; Morgillo, F; DE VITA, F; Bianco, Roberto; Fontanini, G; Bianco, Ar; Tortora, Giampaolo; AND CIARDIELLO, F.
MONOCLONAL ANTIBODIES TARGETING THE EPIDERMAL GROWTH FACTOR RECEPTOR. 1.1 Articolo in rivista 2005 Bianco, Roberto; Daniele, Gennaro; Ciardiello, F; Tortora, Giampaolo
Combination of biological therapies in non-small cell lung cancer. 1.1 Articolo in rivista 2006 Bianco, Roberto; Damiano, Vincenzo; Tortora, Giampaolo
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. 1.1 Articolo in rivista 2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Combined blockade of PKA and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis. 1.1 Articolo in rivista 2001 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
A novel mdm2 antisense oligonucleotide has antitumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancer. 1.1 Articolo in rivista 2000 Tortora, Giampaolo; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Chen, J; Agrawal, S; Bianco, Ar; Ciardiello, F.
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an EGFR-selective tyrosine kinase inhibitor. 1.1 Articolo in rivista 2000 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells. 1.1 Articolo in rivista 1997 Tortora, Giampaolo; DI ISERNIA, G; Sandomenico, C; Bianco, Roberto; Pomatico, G; Pepe, Stefano; Bianco, Ar; Ciardiello, F.
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. 1.1 Articolo in rivista 2003 Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. 1.1 Articolo in rivista 1999 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; Bianco, A. R.; Tortora, Giampaolo
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. 1.1 Articolo in rivista 2000 Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello,
Antiangiogenic and antitumor activity of anti-EGFR C225 monoclonal antibody in combination with Vascular Endothelial Growth Factor antisense oligonucleotide in human GEO colon cancer cells. 1.1 Articolo in rivista 2000 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Caputo, R; Pomatico, G; DE PLACIDO, Sabino; Bianco, Ar; Mendelsohn, J; Tortora, Giampaolo